138 related articles for article (PubMed ID: 12213305)
21. Abnormal intracellular trafficking of high affinity nerve growth factor receptor, Trk, in stable transfectants expressing presenilin 1 protein.
Hamano T; Mutoh T; Tabira T; Araki W; Kuriyama M; Mihara T; Yano S; Yamamoto H
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):70-6. PubMed ID: 15950763
[TBL] [Abstract][Full Text] [Related]
22. Mutant presenilin 1 increases the levels of Alzheimer amyloid beta-peptide Abeta42 in late compartments of the constitutive secretory pathway.
Petanceska SS; Seeger M; Checler F; Gandy S
J Neurochem; 2000 May; 74(5):1878-84. PubMed ID: 10800930
[TBL] [Abstract][Full Text] [Related]
23. FAD-linked Presenilin-1 V97L mutation impede tranport regulation and intracellular Ca(2+) homeostasis under ER stress.
Shao Y; Li M; Wu M; Shi K; Fang B; Wang J
Int J Clin Exp Med; 2015; 8(11):20742-50. PubMed ID: 26884997
[TBL] [Abstract][Full Text] [Related]
24. Hypoxic enhancement of evoked noradrenaline release from the human neuroblastoma SH-SY5Y.
Webster NJ; Vaughan PF; Peers C
Brain Res Mol Brain Res; 2001 Apr; 89(1-2):50-7. PubMed ID: 11311975
[TBL] [Abstract][Full Text] [Related]
25. Aspartyl protease inhibitor pepstatin binds to the presenilins of Alzheimer's disease.
Evin G; Sharples RA; Weidemann A; Reinhard FB; Carbone V; Culvenor JG; Holsinger RM; Sernee MF; Beyreuther K; Masters CL
Biochemistry; 2001 Jul; 40(28):8359-68. PubMed ID: 11444983
[TBL] [Abstract][Full Text] [Related]
26. Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels.
Zatti G; Burgo A; Giacomello M; Barbiero L; Ghidoni R; Sinigaglia G; Florean C; Bagnoli S; Binetti G; Sorbi S; Pizzo P; Fasolato C
Cell Calcium; 2006 Jun; 39(6):539-50. PubMed ID: 16620965
[TBL] [Abstract][Full Text] [Related]
27. Morphological change by overexpression of D385A dominant negative presenilin 1 in human neuroblastoma SH-SY5Y cells.
Tsuchiya D; Kitamura Y; Takata K; Taniguchi T; Uemura K; Miki H; Takenawa T; Shimohama S
J Pharmacol Sci; 2006 Nov; 102(3):354-8. PubMed ID: 17099291
[TBL] [Abstract][Full Text] [Related]
28. The presenilin 2 M239I mutation associated with familial Alzheimer's disease reduces Ca2+ release from intracellular stores.
Zatti G; Ghidoni R; Barbiero L; Binetti G; Pozzan T; Fasolato C; Pizzo P
Neurobiol Dis; 2004 Mar; 15(2):269-78. PubMed ID: 15006697
[TBL] [Abstract][Full Text] [Related]
29. Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells.
Ramalho RM; Borralho PM; Castro RE; Solá S; Steer CJ; Rodrigues CM
J Neurochem; 2006 Sep; 98(5):1610-8. PubMed ID: 16923170
[TBL] [Abstract][Full Text] [Related]
30. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice.
Leissring MA; Akbari Y; Fanger CM; Cahalan MD; Mattson MP; LaFerla FM
J Cell Biol; 2000 May; 149(4):793-8. PubMed ID: 10811821
[TBL] [Abstract][Full Text] [Related]
31. A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years.
Wisniewski T; Dowjat WK; Buxbaum JD; Khorkova O; Efthimiopoulos S; Kulczycki J; Lojkowska W; Wegiel J; Wisniewski HM; Frangione B
Neuroreport; 1998 Jan; 9(2):217-21. PubMed ID: 9507958
[TBL] [Abstract][Full Text] [Related]
32. Capacitative calcium entry induces hippocampal long term potentiation in the absence of presenilin-1.
Ris L; Dewachter I; Reversé D; Godaux E; Van Leuven F
J Biol Chem; 2003 Nov; 278(45):44393-9. PubMed ID: 12902342
[TBL] [Abstract][Full Text] [Related]
33. Reduction of Ca2+ stores and capacitative Ca2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia.
Giacomello M; Barbiero L; Zatti G; Squitti R; Binetti G; Pozzan T; Fasolato C; Ghidoni R; Pizzo P
Neurobiol Dis; 2005 Apr; 18(3):638-48. PubMed ID: 15755689
[TBL] [Abstract][Full Text] [Related]
34. Cholinergic- and stress-induced signaling activities in cells overexpressing wild-type and mutant presenilin-1.
De Sarno P; Lesort M; Bijur GN; Johnson GV; Jope RS
Brain Res; 2001 Jun; 903(1-2):226-30. PubMed ID: 11382407
[TBL] [Abstract][Full Text] [Related]
35. Attenuated presenilin-1 endoproteolysis enhances store-operated calcium currents in neuronal cells.
Ryazantseva M; Skobeleva K; Glushankova L; Kaznacheyeva E
J Neurochem; 2016 Mar; 136(5):1085-95. PubMed ID: 26678016
[TBL] [Abstract][Full Text] [Related]
36. Presenilin regulates capacitative calcium entry dependently and independently of gamma-secretase activity.
Akbari Y; Hitt BD; Murphy MP; Dagher NN; Tseng BP; Green KN; Golde TE; LaFerla FM
Biochem Biophys Res Commun; 2004 Oct; 322(4):1145-52. PubMed ID: 15336962
[TBL] [Abstract][Full Text] [Related]
37. Calcium oscillations in type-1 astrocytes, the effect of a presenilin 1 (PS1) mutation.
Johnston JM; Burnett P; Thomas AP; Tezapsidis N
Neurosci Lett; 2006 Mar; 395(2):159-64. PubMed ID: 16300890
[TBL] [Abstract][Full Text] [Related]
38. The presenilin 1 C92S mutation increases abeta 42 production.
Lewis PA; Perez-Tur J; Golde TE; Hardy J
Biochem Biophys Res Commun; 2000 Oct; 277(1):261-3. PubMed ID: 11027672
[TBL] [Abstract][Full Text] [Related]
39. Presenilin-1 mutations associated with familial Alzheimer's disease do not disrupt protein transport from the endoplasmic reticulum to the Golgi apparatus.
Tan Y; Hong J; Doan T; McConlogue L; Maltese WA
Biochim Biophys Acta; 1998 Jul; 1407(1):69-78. PubMed ID: 9639678
[TBL] [Abstract][Full Text] [Related]
40. Alzheimer's presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate-mediated calcium signaling in Xenopus oocytes.
Leissring MA; Paul BA; Parker I; Cotman CW; LaFerla FM
J Neurochem; 1999 Mar; 72(3):1061-8. PubMed ID: 10037477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
